Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. on March 13, 2014. The filing discloses the completion of a private placement offering of unsecured convertible promissory notes to accredited investors.
Key Financial Metrics and Obligations
- Total Notes Issued: $1,793,000 in aggregate original principal amount.
- Additional Notes Issued: $1,042,000 issued between the filing of the Q4 2013 10-Q and March 13, 2014.
- Interest Rate: 5% per annum, non-compounding.
- Maturity Date: June 30, 2014 (all principal and interest due).
- Warrants Issued: 896,500 total warrants issued during the offering; 521,000 warrants issued with the Additional Notes.
- Warrant Terms: Exercise price of $0.49 per share; exercisable starting May 31, 2014; expiration December 31, 2018.
- Transaction Costs: Total cash commission of $110,110 and finance fee of $31,460 paid to Emergent Financial Group, Inc.
Material Changes and Terms
The filing details the creation of a direct financial obligation through the issuance of convertible notes. Key terms include:
- Subsequent Offering Conversion: If Cryoport issues new equity while notes are outstanding, note holders may convert principal and accrued interest into shares at 90% of the new offering price within ten days of notice.
- Voluntary Conversion Option: After January 31, 2014, the company may offer holders the right to convert notes into units of shares and warrants. The conversion price would be 70% of the 10-day VWAP, with warrants exercisable at 110% of that VWAP.
- Prepayment: The company may not prepay the notes.
Outlook, Risks, and Contingencies
The filing does not provide specific forward-looking guidance or management commentary regarding future operations beyond the terms of the notes. The primary risk disclosed is the dilution potential inherent in the conversion features and the immediate liquidity obligation of $1,793,000 plus accrued interest due on June 30, 2014. The offering was conducted under Regulation D and Section 4(2) exemptions, limiting the investor base to accredited investors.
Investor Verification Checklist
- Verify the company's ability to repay $1,793,000 plus accrued interest by the June 30, 2014 maturity date.
- Review the full terms of the Notes filed as an exhibit to the Form 10-K for the fiscal year ended March 31, 2014.
- Assess the potential dilution impact of 896,500 warrants and the conversion features tied to future equity offerings.
- Confirm the total cash outflow for transaction fees ($141,570 total) and its impact on current liquidity.